NCT01232985View on ClinicalTrials.gov

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Atopic DermatitisPruritus
Interventions
DEVICE

RD047-26

RD047-26 emollient gel

Trial Locations (1)

27262

Dermatology Consulting Services, High Point

Sponsors
All Listed Sponsors
lead

Oculus Innovative Sciences, Inc.

INDUSTRY

NCT01232985 - Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults | Biotech Hunter | Biotech Hunter